乳腺恶性淋巴瘤临床病理分析  

The Clinico-pathological Features of Malignant Breast Lymphoma

作　　者：刘雪娟[1] 

机构地区：[1]四川大学华西医院甲状腺外科,成都610041

出　　处：《华西医学》2011年第2期207-209,共3页West China Medical Journal

摘　　要：目的探讨乳腺恶性淋巴瘤的临床病理特征、治疗方式及其与预后关系。方法 1980年1月2007年12月对收治的21例乳腺恶性淋巴瘤患者的临床病理特点、诊断和治疗方法进行回顾性分析。结果 21例乳腺恶性淋巴瘤患者均为女性,中位年龄47岁;其中原发性乳腺恶性淋巴瘤18例,继发性恶性淋巴瘤3例。原发性乳腺恶性淋巴瘤均为非霍奇金淋巴瘤,B细胞来源为主,大多为术后诊断,治疗均采用手术+化学疗法。结论乳腺恶性淋巴瘤治疗应强调手术,化学疗法和放射治疗的综合治疗。Objective To study the clinico-pathological features and treatment modality of malignant breast lymphoma,and their relationships with the prognosis of the disease.Methods The clinico-pathological features,diagnosis and treatment methods of 21 cases of malignant breast lymphoma diagnosed between January 1980 and December 2007 were analyzed retrospectively and related domestic and overseas literature was reviewed.Results Among the 21 female patients,18 had primary breast lymphoma（PBL）,3 had secondary breast lymphoma.All cases of PBL were non-Hodgkin’s lymphoma with mainly B cells as the origin.The median age of the patients was 46.5 years old.Most of the cases were diagnosed postoperatively and all patients were treated by operation combined with chemotherapy.Related literature reviewing showed that clinical staging and treatment modality were important factors of prognosis.Conclusion In treating malignant breast lymphoma,operation and chemoradiotherapy should be combined together to get a better result.

关 键 词：乳腺 恶性淋巴瘤 临床分析 

分 类 号：R737.9[医药卫生—肿瘤]